NICE Guidance on Temozolomide

• TA121 Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide: understanding NICE guidance

• TA121 Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide: understanding NICE guidance (MS Word format)

• TA23 Brain cancer - temozolomide: Information for the public (pdf)

2. Background informatioN

• 2007/034 NICE issues guidance on the use of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

3. Further information NICE has produced to help the NHS implement this guideline locally is linked to below:

• TA121 Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide: costing template – TA121Costing

• Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide: audit criteria - TA121AuditCriteria

This page was last modified on 25th November 2011 at 02:10